The global virology specimen collection market size was valued at USD 5.6 Billion in 2021 and is estimated to experience a negative CAGR of -0.5% during the forecast period of 2022 to 2032.
Growth of the market can be attributed to:
During the COVID-19 pandemic, the growth of the market was stagnated owing to nation wide lockdowns. On the other hand, testing of virus specimens became essential owing to the urgent need for curbing viruses.
Technological advancements in the field of specimen collection have made it easier for exchange of information regarding viruses. As the nature of viruses differ from region to region owing to mutation of the same, the market for virology specimen collection has gained traction.
The outbreak of Zika virus and Babesia alongside announcements for their inclusion in virology specimen collection tests have indicated the need for innovation in virology specimen collection technologies, consumables, and instruments.
Other countries have also undertaken initiatives to check for new and emerging diseases. In addition, the prevalence of EBOLA, Zika virus, SARS-CoV-2, AIDS, flu, and STDs is driving the growth for virology specimen collection market.
| Attributes | Details |
|---|---|
| Virology Specimen Collection Market CAGR (2022 to 2032) | -0.5% |
| Virology Specimen Collection Market (2026) | USD 5.3 Billion |
| Virology Specimen Collection Market Attraction | Innovation in specimen collection devices technologies to keep the global market attractive |
High awareness levels regarding the disease transmission, diagnosis, and effective management of microbial infections have been observed in North America. In addition, government initiatives to support product development for virology specimen collection is influencing market growth.
In addition, large share of North America in this market can be attributed to the increasing adoption of NAT (due to the high prevalence of TTIs). Furthermore, technological developments including portable diagnostics is favoring the growth of the market.
Growing income levels, greater health awareness, and the rising incidence of lifestyle diseases is contributing to the growth of virology specimen collection market. Currently, ELISA is widely used in India, with NAT registering relatively low penetration.
Emerging markets such as India, the Middle East, and Africa offer promising opportunities for players in the virology specimen collection industry due to their increasing disposable incomes and improving healthcare infrastructure.
NAT is still not mandatory in India, thus, states in India are using NAT in ID-NAT format. For Instance, AIIMS, PGI Chandigarh, CMC Vellore, Medanta-The Medicity, and Narayana Hrudayalaya, are using, and 40 blood banks are using the pooling technique. Similarly, the Indian government is taking initiatives to train doctors, hospitals, and blood banks to use NAT.
On the other hand, regions like US, Canada, most of Europe, Japan, Korea, Singapore, Sri Lanka, UAE, South Africa, Thailand, and China. Almost 100 blood banks are using Nat for virology specimen collection.
The growth virology specimen collection market has stagnated in recent times because of the diverted focus of public healthcare resources towards the detection of widespread coronavirus infections.
The frequent outbreak of viral diseases in different parts of the world has provided the necessary impetus for adopting successful innovations in the virology specimen collection processes and devices. Market players in the high-income countries are at the forefront of taking advantage of these facilities to dominate the global microbiology specimen collection market.
ELISA is a main source for diagnosis because of its affordability, although enhanced sources are still prohibitively expensive, posing a market problem.
In the short term, relying on ELISA is a crucial impediment to the growth of NAT's virology specimen collection market. Due to the high expense of sophisticated testing, earlier, less efficient tests, such as first-generation ELISA, are being used more frequently. Flu, Zika virus, STDs, AIDS, and Ebola virus public awareness campaigns are also a crucial component in raising public knowledge and, as a result, affecting the market growth.
While it is encouraging that new diagnostic techniques are becoming accessible to improve clinical treatment in low-resource settings, the cost of each test is a significant barrier to acceptance and long-term use.
Only giant corporations can afford significant capital expenditures and high R&D and manufacturing costs. New entrants will be unable to enter the market due to this.
The demands a decrease in the cost of microbiology specimen collection products will continue to stifle market expansion until it is met and overcome.
The epidemics of Zika and Babesia and news that they would be included in virology specimen collecting tests highlight the need for new microbiology specimen collection technologies, consumables, and equipment. Other governments have launched their efforts to monitor new and emerging illnesses.
The prevalence of malaria in African countries, collection, transportation, and storage of samples for viral diagnosis and the risk of Zika virus transmission via mosquitos has resulted in regulations for Zika virus screening across the region. Various medium solutions have been suggested for stabilizing specimens to identify bacteria and viruses, especially during diagnostic investigations.
To strengthen pandemic management, microbiology specimen collection and future preparedness for COVID-19 and other infectious diseases, international strategies for the regulation, evaluation, and use of digital technologies such as digital epidemiological surveillance, rapid case identification, interruption of community transmission, transport of viral specimen and future preparedness for COVID-19 and other infectious diseases must be aligned.
A variety of protein supplements have been and continue to be prescribed to improve viral stability. These are generally made up of balanced salt or saline solutions with a buffering ability to keep the pH close to neutral. While some laboratories collect, transport, and store samples for viral diagnosis, commercial preparations are often utilized and generally come with sterile swabs as part of a sample collection kit.
The overall growth of global virology specimen collection market comes from the united growth of virology transport media and nasopharyngeal sample.
The global market study on the virology specimen collection market is segmented into categories; Product type sample. These categories and their segment’s performance differ with different regions. There are segments like blood collection kits, specimen collection, viral transport media, and swabs based on product type.
Based on the sample, the segments are blood samples, nasopharyngeal samples, throat samples, cervical samples, oral samples and other samples. The services related to it are virology sample collection, laboratory testing and microbiology specimen collection.
The virology specimen collection market report tells that the virology transport media segment is likely to perform better than any other segment of product type categories. The reason behind the growth of this specific segment is the high number of blood donations having all around the world.
Also, the emergence of new pathogens is driving the force behind the sales of virology specimen collection and virology transport media. Consumers are getting aware about the global blood banks with the increasing number of cancer cases, which encourages them to donate blood.
The nasopharyngeal sample segment holds the most significant portion of the market share. The primary reason behind that is the fast detection of transmissible transfusion infection (TTIs) and the increased prevalence of HPV-related cancers (all cervical cancers) & human papillomavirus (HPV).
The transmissible infections led to nasopharyngeal samples more often in the healthcare and medical industry. Emerging trends in the virology specimen collection market also estimate that the nasopharyngeal samples are likely to witness the highest sales post the forecast period.
The market for virology specimen collection is highly consolidated. In the virology specimen collection market, the key players are Becton, Dickinson and Company (USA), Quidel Corporation (USA), Thermo Fisher Scientific Inc. (USA), Trinity Biotech (Ireland), and Titan Biotech Ltd. (India). These key players accounted for a combined majority market share in 2020.
There is fierce competition among Key players in the virology specimen collection market. Only major corporations can afford significant capital expenditures and high R&D and manufacturing costs. New entrants will face difficulties entering the virology specimen collection market due to this.
Along with these considerations comes the requirement for the application of digital technology, such as digital epidemiological surveillance, future preparation for COVID-19 and other infectious illnesses, pandemic management, community transmission interruption, and rapid case identification. As a result of these factors, the virology specimen collection market is expected to have numerous potential opportunities in future years.
Table 1: Global Market Value (US$ Mn), By Product Type, 2015 – 2021
Table 2: Global Market Value (US$ Mn), By Product Type, 2022 – 2032
Table 3: Global Market Value (US$ Mn), By Sample, 2015 – 2021
Table 4: Global Market Value (US$ Mn), By Sample, 2022 – 2032
Table 5: Global Market, By Region, 2015 – 2021
Table 6: Global Market, By Region, 2022 – 2032
Table 7: North America Market Value (US$ Mn), By Product Type, 2015 – 2021
Table 8: North America Market Value (US$ Mn), By Product Type, 2022 – 2032
Table 9: North America Market Value (US$ Mn), By Sample, 2015 – 2021
Table 10: North America Market Value (US$ Mn), By Sample, 2022 – 2032
Table 11: North America Market, By Country, 2015 – 2021
Table 12: North America Market, By Country, 2022 – 2032
Table 13: Latin America Market Value (US$ Mn), By Product Type, 2015 – 2021
Table 14: Latin America Market Value (US$ Mn), By Product Type, 2022 – 2032
Table 15: Latin America Market Value (US$ Mn), By Sample, 2015 – 2021
Table 16: Latin America Market Value (US$ Mn), By Sample, 2022 – 2032
Table 17: Latin America Market, By Country, 2015 – 2021
Table 18: Latin America Market, By Country, 2022 – 2032
Table 19: Europe Market Value (US$ Mn), By Product Type, 2015 – 2021
Table 20: Europe Market Value (US$ Mn), By Product Type, 2022 – 2032
Table 21: Europe Market Value (US$ Mn), By Sample, 2015 – 2021
Table 22: Europe Market Value (US$ Mn), By Sample, 2022 – 2032
Table 23: Europe Market, By Country, 2015 – 2021
Table 24: Europe Market, By Country, 2022 – 2032
Table 25: Asia Pacific Market Value (US$ Mn), By Product Type, 2015 – 2021
Table 26: Asia Pacific Market Value (US$ Mn), By Product Type, 2022 – 2032
Table 27: Asia Pacific Market Value (US$ Mn), By Sample, 2015 – 2021
Table 28: Asia Pacific Market Value (US$ Mn), By Sample, 2022 – 2032
Table 29: Asia Pacific Market, By Country, 2015 – 2021
Table 30: Asia Pacific Market, By Country, 2022 – 2032
Table 31: MEA Market Value (US$ Mn), By Product Type, 2015 – 2021
Table 32: MEA Market Value (US$ Mn), By Product Type, 2022 – 2032
Table 33: MEA Market Value (US$ Mn), By Sample, 2015 – 2021
Table 34: MEA Market Value (US$ Mn), By Sample, 2022 – 2032
Table 35: MEA Market, By Country, 2015 – 2021
Table 36: MEA Market, By Country, 2022 – 2032
Table 37: Global Market Incremental $ Opportunity, By Product Type, 2015 - 2021
Table 38: Global Market Incremental $ Opportunity, By Sample, 2022 – 2032
Table 39: Global Market Incremental $ Opportunity, By Region, 2022 – 2032
Table 40: North America Market Incremental $ Opportunity, By Product Type, 2015 - 2021
Table 41: North America Market Incremental $ Opportunity, By Sample, 2022 – 2032
Table 42: North America Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 43: Latin America Market Incremental $ Opportunity, By Product Type, 2015 - 2021
Table 44: Latin America Market Incremental $ Opportunity, By Sample, 2022 – 2032
Table 45: Latin America Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 46: Europe Market Incremental $ Opportunity, By Product Type, 2015 - 2021
Table 47: Europe Market Incremental $ Opportunity, By Sample, 2022 – 2032
Table 48: Europe Market Incremental $ Opportunity, By Country, 2022 - 2032
Table 49: Asia Pacific Market Incremental $ Opportunity, By Product Type, 2015 - 2021
Table 50: Asia Pacific Market Incremental $ Opportunity, By Sample, 2022 – 2032
Table 51: Asia Pacific Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 52: MEA Market Incremental $ Opportunity, By Product Type, 2015 - 2021
Table 53: MEA Market Incremental $ Opportunity, By Sample, 2022 – 2032
Table 54: MEA Market Incremental $ Opportunity, By Country, 2022 - 2032
Figure 1: Global Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 2: Global Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 3: Global Market Share, By Product Type, 2022 & 2032
Figure 4: Global Market Y-o-Y Growth Projections, By Product Type – 2022-2032
Figure 5: Global Market Attractiveness Index, By Product Type – 2022-2032
Figure 6: Global Market Share, By Sample, 2022 & 2032
Figure 7: Global Market Y-o-Y Growth Projections, By Sample – 2022-2032
Figure 8: Global Market Attractiveness Index, By Sample – 2022-2032
Figure 9: Global Market Share, By Region, 2022 & 2032
Figure 10: Global Market Y-o-Y Growth Projections, By Region – 2022-2032
Figure 11: Global Market Attractiveness Index, By Region – 2022-2032
Figure 12: North America Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 13: North America Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 14: North America Market Share, By Product Type, 2022 & 2032
Figure 15: North America Market Y-o-Y Growth Projections, By Product Type – 2022-2032
Figure 16: North America Market Attractiveness Index, By Product Type – 2022-2032
Figure 17: North America Market Share, By Sample, 2022 & 2032
Figure 18: North America Market Y-o-Y Growth Projections, By Sample – 2022-2032
Figure 19: North America Market Attractiveness Index, By Sample – 2022-2032
Figure 20: North America Market Share, By Country, 2022 & 2032
Figure 21: North America Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 22: North America Market Attractiveness Index, By Country – 2022-2032
Figure 23: Latin America Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 24: Latin America Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 25: Latin America Market Share, By Product Type, 2022 & 2032
Figure 26: Latin America Market Y-o-Y Growth Projections, By Product Type – 2022-2032
Figure 27: Latin America Market Attractiveness Index, By Product Type – 2022-2032
Figure 28: Latin America Market Share, By Sample, 2022 & 2032
Figure 29: Latin America Market Y-o-Y Growth Projections, By Sample – 2022-2032
Figure 30: Latin America Market Attractiveness Index, By Sample – 2022-2032
Figure 31: Latin America Market Share, By Country, 2022 & 2032
Figure 32: Latin America Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 33: Latin America Market Attractiveness Index, By Country – 2022-2032
Figure 34: Europe Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 35: Europe Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 36: Europe Market Share, By Product Type, 2022 & 2032
Figure 37: Europe Market Y-o-Y Growth Projections, By Product Type – 2022-2032
Figure 38: Europe Market Attractiveness Index, By Product Type – 2022-2032
Figure 39: Europe Market Share, By Sample, 2022 & 2032
Figure 40: Europe Market Y-o-Y Growth Projections, By Sample – 2022-2032
Figure 41: Europe Market Attractiveness Index, By Sample – 2022-2032
Figure 42: Europe Market Share, By Country, 2022 & 2032
Figure 43: Europe Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 44: Europe Market Attractiveness Index, By Country – 2022-2032
Figure 45: MEA Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 46: MEA Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 47: MEA Market Share, By Product Type, 2022 & 2032
Figure 48: MEA Market Y-o-Y Growth Projections, By Product Type – 2022-2032
Figure 49: MEA Market Attractiveness Index, By Product Type – 2022-2032
Figure 50: MEA Market Share, By Sample, 2022 & 2032
Figure 51: MEA Market Y-o-Y Growth Projections, By Sample – 2022-2032
Figure 52: MEA Market Attractiveness Index, By Sample – 2022-2032
Figure 53: MEA Market Share, By Country, 2022 & 2032
Figure 54: MEA Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 55: MEA Market Attractiveness Index, By Country – 2022-2032
Figure 56: Asia Pacific Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 57: Asia Pacific Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 58: Asia Pacific Market Share, By Product Type, 2022 & 2032
Figure 59: Asia Pacific Market Y-o-Y Growth Projections, By Product Type – 2022-2032
Figure 60: Asia Pacific Market Attractiveness Index, By Product Type – 2022-2032
Figure 61: Asia Pacific Market Share, By Sample, 2022 & 2032
Figure 62: Asia Pacific Market Y-o-Y Growth Projections, By Sample – 2022-2032
Figure 63: Asia Pacific Market Attractiveness Index, By Sample – 2022-2032
Figure 64: Asia Pacific Market Share, By Country, 2022 & 2032
Figure 65: Asia Pacific Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 66: Asia Pacific Market Attractiveness Index, By Country – 2022-2032
Figure 67: US Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 68: US Market Share, By Product Type, 2021
Figure 69: US Market Share, By Sample, 2021
Figure 70: Canada Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 71: Canada Market Share, By Product Type, 2021
Figure 72: Canada Market Share, By Sample, 2021
Figure 73: Brazil Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 74: Brazil Market Share, By Product Type, 2021
Figure 75: Brazil Market Share, By Sample, 2021
Figure 76: Mexico Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 77: Mexico Market Share, By Product Type, 2021
Figure 78: Mexico Market Share, By Sample, 2021
Figure 79: Germany Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 80: Germany Market Share, By Product Type, 2021
Figure 81: Germany Market Share, By Sample, 2021
Figure 82: U.K. Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 83: U.K. Market Share, By Product Type, 2021
Figure 84: U.K. Market Share, By Sample, 2021
Figure 85: France Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 86: France Market Share, By Product Type, 2021
Figure 87: France Market Share, By Sample, 2021
Figure 88: Italy Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 89: Italy Market Share, By Product Type, 2021
Figure 90: Italy Market Share, By Sample, 2021
Figure 91: BENELUX Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 92: BENELUX Market Share, By Product Type, 2021
Figure 93: BENELUX Market Share, By Sample, 2021
Figure 94: Nordic Countries Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 95: Nordic Countries Market Share, By Product Type, 2021
Figure 96: Nordic Countries Market Share, By Sample, 2021
Figure 97: China Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 98: China Market Share, By Product Type, 2021
Figure 99: China Market Share, By Sample, 2021
Figure 100: Japan Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 101: Japan Market Share, By Product Type, 2021
Figure 102: Japan Market Share, By Sample, 2021
Figure 103: South Korea Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 104: South Korea Market Share, By Product Type, 2021
Figure 105: South Korea Market Share, By Sample, 2021
Figure 106: GCC Countries Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 107: GCC Countries Market Share, By Product Type, 2021
Figure 108: GCC Countries Market Share, By Sample, 2021
Figure 109: South Africa Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 110: South Africa Market Share, By Product Type, 2021
Figure 111: South Africa Market Share, By Sample, 2021
Figure 112: Turkey Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 113: Turkey Market Share, By Product Type, 2021
Figure 114: Turkey Market Share, By Sample, 2021
The blood sample segment accounts for the highest growth rate.
Asia Pacific is predicted to experience the highest growth rate.
Need for alternative technologies for testing of virology samples is a major restraint.
The growth of the virology specimen collection market is likely to be USD 5.3 Billion by 2026.
The virology specimen collection market is likely to remain negative during the forecast period.
Explore Similar Insights
Virology Specimen Collection Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
